Perampanel in real-world clinical care of adolescent and adult patients with epilepsy: Results from the retrospective Phase IV PROVE Study

•PROVE was a retrospective, non-interventional phase IV study of perampanel.•This analysis evaluated final data from adolescent and adult patients.•Perampanel was associated with favorable retention rates and sustained efficacy.•No new safety signals were observed with perampanel in adolescent and adult patients.